HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Incidence and risk factors for the development of prolonged severe intrahepatic cholestasis after pediatric living-donor liver transplantation.

Abstract
The aim of this study is to evaluate the incidence, etiology, and risk facrors for prolonged severe intrahepatic cholestasis (PSIC) after 129 pediatric living-donor liver transplantations (LDLT). The incidence of PSIC was 25.6% (n = 33). Twenty-eight (84.8%) versus 5 (15.2%) children experienced early versus late PSIC, respectively. Among these 33 children with PSIC, 8 (24.2%) received a donor liver with mild to moderate fatty change, 4 (12.1%) with low graft-body weight ratios, and 4 (12.1%) with ABO incompatibility. The predominant etiologies were acute rejection (n = 15; 45.5%), chronic rejection (n = 6; 18.2%), virus (n = 3; 9.1%), vascular complications (n = 4; 12.1%), and initial graft dysfunction (n = 10; 30.3%). ABO incompatibility (P = .032; odds ratio [OR] 3.25), chronic rejection (P = .012; OR 4.76), and vascular complications (P = .046; OR 1.82) were significant variables associated with PSIC. Donor selection with ABO compatibility as well as early detection and management of chronic rejection and vascular complications may be important to prevet PSIC in LDLT.
AuthorsS H Oh, K M Kim, D Y Kim, T Kim, S Hwang, K-M Park, Y-J Lee, S-G Lee
JournalTransplantation proceedings (Transplant Proc) 2011 Jul-Aug Vol. 43 Issue 6 Pg. 2400-2 ISSN: 1873-2623 [Electronic] United States
PMID21839277 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • ABO Blood-Group System
Topics
  • ABO Blood-Group System (immunology)
  • Adolescent
  • Blood Group Incompatibility (complications, immunology)
  • Child
  • Child, Preschool
  • Cholestasis, Intrahepatic (epidemiology, etiology, mortality)
  • Donor Selection
  • Graft Rejection (etiology, immunology)
  • Histocompatibility
  • Humans
  • Incidence
  • Infant
  • Kaplan-Meier Estimate
  • Liver Transplantation (adverse effects, immunology, mortality)
  • Living Donors
  • Logistic Models
  • Odds Ratio
  • Republic of Korea
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Survival Rate
  • Time Factors
  • Treatment Outcome
  • Vascular Diseases (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: